Apollo Hospitals [APOLLOHOSP] vs Global Health [MEDANTA] Detailed Stock Comparison

Apollo Hospitals
NSE
Loading...

Global Health
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Apollo Hospitals wins in 9 metrics, Global Health wins in 10 metrics, with 0 ties. Global Health appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | Apollo Hospitals | Global Health | Better |
---|---|---|---|
P/E Ratio (TTM) | 73.17 | 74.47 | Apollo Hospitals |
Price-to-Book Ratio | 12.87 | 10.62 | Global Health |
Debt-to-Equity Ratio | 90.89 | 21.19 | Global Health |
PEG Ratio | 90.09 | 57.13 | Global Health |
EV/EBITDA | 36.80 | 40.56 | Apollo Hospitals |
Profit Margin (TTM) | 6.63% | 13.04% | Global Health |
Operating Margin (TTM) | 9.99% | 18.84% | Global Health |
EBITDA Margin (TTM) | 9.99% | 18.84% | Global Health |
Return on Equity | 18.85% | 15.30% | Apollo Hospitals |
Return on Assets (TTM) | 7.57% | 9.42% | Global Health |
Free Cash Flow (TTM) | $4.24B | $-241.56M | Apollo Hospitals |
Dividend Yield | 0.27% | N/A | N/A |
1-Year Return | 9.56% | 10.53% | Global Health |
Price-to-Sales Ratio (TTM) | 4.85 | 9.73 | Apollo Hospitals |
Enterprise Value | $1,112.00B | $355.71B | Apollo Hospitals |
EV/Revenue Ratio | 5.10 | 9.63 | Apollo Hospitals |
Gross Profit Margin (TTM) | 47.63% | 77.06% | Global Health |
Revenue per Share (TTM) | $1,516 | $137 | Apollo Hospitals |
Earnings per Share (Diluted) | $100.47 | $17.96 | Apollo Hospitals |
Beta (Stock Volatility) | 0.28 | -0.34 | Global Health |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Apollo Hospitals vs Global Health Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Apollo Hospitals | -0.59% | -1.57% | -1.93% | 6.11% | 7.71% | -0.25% |
Global Health | -0.97% | 1.09% | 16.16% | 10.89% | 24.44% | 21.51% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Apollo Hospitals | 9.56% | 68.07% | 321.72% | 411.62% | 1,741.56% | 3,793.80% |
Global Health | 10.53% | 222.95% | 222.95% | 222.95% | 222.95% | 222.95% |
Performance & Financial Health Analysis: Apollo Hospitals vs Global Health
Metric | APOLLOHOSP | MEDANTA |
---|---|---|
Market Information | ||
Market Cap | ₹1.06T | ₹359.41B |
Market Cap Category | Large cap | Large cap |
10 Day Avg. Volume | 331,835 | 244,518 |
90 Day Avg. Volume | 461,715 | 432,810 |
Last Close | ₹7,308.00 | ₹1,324.50 |
52 Week Range | ₹6,001.00 - ₹7,635.00 | ₹935.50 - ₹1,393.20 |
% from 52W High | -4.28% | -4.93% |
All-Time High | ₹552,030.00 (Nov 20, 2023) | ₹1,513.90 (Feb 12, 2024) |
% from All-Time High | -98.68% | -12.51% |
Growth Metrics | ||
Quarterly Revenue Growth | 0.13% | 0.13% |
Quarterly Earnings Growth | 0.54% | -0.20% |
Financial Health | ||
Profit Margin (TTM) | 0.07% | 0.13% |
Operating Margin (TTM) | 0.10% | 0.19% |
Return on Equity (TTM) | 0.19% | 0.15% |
Debt to Equity (MRQ) | 90.89 | 21.19 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | ₹571.24 | ₹125.91 |
Cash per Share (MRQ) | ₹194.24 | ₹41.73 |
Operating Cash Flow (TTM) | ₹21.36B | ₹6.24B |
Levered Free Cash Flow (TTM) | ₹1.37B | ₹840.50M |
Dividends | ||
Last 12-Month Dividend Yield | 0.27% | N/A |
Last 12-Month Dividend | ₹19.00 | N/A |
Valuation & Enterprise Metrics Analysis: Apollo Hospitals vs Global Health
Metric | APOLLOHOSP | MEDANTA |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 73.17 | 74.47 |
Forward P/E | 90.09 | 57.13 |
PEG Ratio | 90.09 | 57.13 |
Price to Sales (TTM) | 4.85 | 9.73 |
Price to Book (MRQ) | 12.87 | 10.62 |
Market Capitalization | ||
Market Capitalization | ₹1.06T | ₹359.41B |
Enterprise Value | ₹1.11T | ₹355.71B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 5.10 | 9.63 |
Enterprise to EBITDA | 36.80 | 40.56 |
Risk & Other Metrics | ||
Beta | 0.28 | -0.34 |
Book Value per Share (MRQ) | ₹571.24 | ₹125.91 |
Financial Statements Comparison: Apollo Hospitals vs Global Health
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | APOLLOHOSP | MEDANTA |
---|---|---|
Revenue/Sales | ₹55.92B | ₹9.31B |
Cost of Goods Sold | ₹29.29B | ₹2.14B |
Gross Profit | ₹26.64B | ₹7.18B |
Research & Development | N/A | N/A |
Operating Income (EBIT) | ₹5.59B | ₹1.61B |
EBITDA | ₹8.41B | ₹2.33B |
Pre-Tax Income | ₹5.16B | ₹1.33B |
Income Tax | ₹1.01B | ₹320.60M |
Net Income (Profit) | ₹4.15B | ₹1.01B |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | APOLLOHOSP | MEDANTA |
---|---|---|
Cash & Equivalents | ₹5.78B | ₹2.30B |
Total Current Assets | ₹70.29B | ₹15.33B |
Total Current Liabilities | ₹45.79B | ₹6.19B |
Long-Term Debt | ₹68.31B | ₹6.24B |
Total Shareholders Equity | ₹86.53B | ₹33.88B |
Retained Earnings | N/A | N/A |
Property, Plant & Equipment | ₹98.16B | ₹25.08B |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | APOLLOHOSP | MEDANTA |
---|---|---|
Operating Cash Flow | N/A | ₹1.40B |
Capital Expenditures | N/A | ₹-661.90M |
Free Cash Flow | N/A | ₹828.74M |
Debt Repayment | N/A | ₹71.87M |
Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
Metric | APOLLOHOSP | MEDANTA |
---|---|---|
Shares Short | N/A | N/A |
Short Ratio | N/A | N/A |
Short % of Float | N/A | N/A |
Average Daily Volume (10 Day) | 331,835 | 244,518 |
Average Daily Volume (90 Day) | 461,715 | 432,810 |
Shares Outstanding | 143.78M | 268.59M |
Float Shares | 98.37M | 87.25M |
% Held by Insiders | 0.30% | 0.68% |
% Held by Institutions | 0.48% | 0.21% |
Dividend Analysis & Yield Comparison: Apollo Hospitals vs Global Health
Metric | APOLLOHOSP | MEDANTA |
---|---|---|
Last 12-Month Dividend | ₹19.00 | N/A |
Last 12-Month Dividend Yield | 0.27% | N/A |
3-Year Avg Annual Dividend | ₹20.25 | N/A |
3-Year Avg Dividend Yield | 0.17% | N/A |
3-Year Total Dividends | ₹60.75 | N/A |
Ex-Dividend Date | Feb 14, 2025 | N/A |